SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-17-050681
Filing Date
2017-09-29
Accepted
2017-09-29 16:02:16
Documents
2
Group Members
BRIAN D. GROSSMANCHRISTOPHER M. JAMESPARTNER FUND MANAGEMENT GP, LLCPARTNER INVESTMENT MANAGEMENT GP, LLCPARTNER INVESTMENT MANAGEMENT, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G v476102_13g.htm SC 13G 148206
2 JOINT FILING AGREEMENT v476102_ex99-1.htm EX-99.1 8161
  Complete submission text file 0001144204-17-050681.txt   158075
Mailing Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111
Business Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111 415-281-1022
Partner Fund Management, L.P. (Filed by) CIK: 0001442756 (see all company filings)

IRS No.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89831 | Film No.: 171111527
SIC: 2836 Biological Products, (No Diagnostic Substances)